Newsletter | September 25, 2018

09.25.18 -- Discovery Helps Fight Against Drug-Resistant Tuberculosis

Industry Insights
Why Early Investment In A Scalable Manufacturing Process Is Critical
Article | By Enrico Corona, Patheon

The failure of drug compounds in mid- to late-stage development is far more common than anyone would like it to be. Only about 30% of compounds successfully transition from Phase II to Phase III.

The Potential For CRISPR Gene Editing In HIV
Article | By Leala Thomas, Bio-Rad Laboratories, Inc.

The advent of CRISPR as a gene editing tool continues to revolutionize drug discovery and development.

Can A Shared Biomanufacturing Facility Be The Answer To The Demand Forecasting Dilemma?
Article | By David Radspinner, et al., GE Healthcare Life Sciences

Using a shared biomanufacturing facility, a biomanufacturer can minimize its investment while mitigating the risks of demand uncertainty and maximizing time to market.

SAR Trek
Article | PerkinElmer, Inc.

Find solutions that allow you to rapidly locate and assemble accurate, comprehensive and workable data sets for detailed and scientifically intelligent refinement and analysis.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.